Similar Papers

Paper Title
Journal
Date
Author
Clinical and immunological analyses of immune checkpoint inhibitor-associated neuromuscular (NM) toxicities.
Bilal A Siddiqui ... Matthew T Campbell
Journal of Clinical Oncology | VOL. 37
Bilal A Siddiqui, et. al.Bilal A Siddiqui ... Matthew T Campbell
20 May 2019
THU0336 IMMUNE CHECKPOINT INHIBITOR-RELATED MYOSITIS: A RETROSPECTIVE COHORT STUDY
...
-
, et. al. ...
01 Jun 2020
Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis-A Case Series.
Nikhil Aggarwal ... Jennifer Turner
Case Reports in Medicine | VOL. 2024
Nikhil Aggarwal, et. al.Nikhil Aggarwal ... Jennifer Turner
29 Mar 2024
Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
Demis N Lipe ... Adriana H Wechsler
The American Journal of Emergency Medicine | VOL. 46
Demis N Lipe, et. al.Demis N Lipe ... Adriana H Wechsler
08 Mar 2021
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Missed Opportunity for Sotorasib Dose Optimization
Garth W Strohbehn ... Mark J Ratain
Journal of Clinical Oncology | VOL. -
Garth W Strohbehn, et. al.Garth W Strohbehn ... Mark J Ratain
06 Feb 2025
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
Sapna P Patel ... Theresa Medina
Journal of Clinical Oncology | VOL. -
Sapna P Patel, et. al.Sapna P Patel ... Theresa Medina
06 Feb 2025
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.